Stockreport

Cabaletta Bio: Curative Medicines For Autoimmunity [Seeking Alpha]

Cabaletta Bio, Inc.  (CABA) 
PDF SummaryCabaletta Bio is pioneering the use of CAAR-T cell therapies to potentially cure various autoimmune diseases.Autoimmunity is a large market, at least $100B, but o [Read more]